Takeda: all 1,753 studies

Page 17 of 18. Open to participants first (93), then studies with results posted, then the rest; newest registration first within each.

• Prucalopride in Patients With Chronic Idiopathic ConstipationCompletedNCT00575614Phase 2
• Safety Study of TAK-700 in Subjects With Prostate Cancer.CompletedNCT00569153Phase 1/2
• Safety of Ramelteon in Elderly SubjectsCompletedNCT00568789Phase 4
• Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)CompletedNCT00567723
• ADDERALL XR (Mixed Salts of a Single-entity Amphetamine) and STRATTERA ( Atomoxetine Hydrochloride) Compared to Placebo on Simulated Driving Safety and Performance and Cognitive Functioning in Adults With ADHDCompletedNCT00557960Phase 3
• NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHDCompletedNCT00557011Phase 2
• Phase 3 Randomized Double-Blind Placebo-Controlled Study of NRP104 in Children Aged 6-12 With ADHDCompletedNCT00556296Phase 3
• Efficacy of Matrifen in Patients Older Than 18 Years With Severe, Chronic PainCompletedNCT00556270
• Efficacy and Safety of Two Doses of SPD476 (Mesalazine) 2.4g and 4.8g Once Daily, With Reference to Asacol 0.8g Three Times Daily in Subjects With Acute, Mild to Moderate Ulcerative ColitisCompletedNCT00548574Phase 3
• Non-interventional Trial About Treatment of Haemorrhages in Cholecystectomy With TachoSil (TC-027-DE)CompletedNCT00546169
• Phase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476CompletedNCT00545389Phase 2
• A Safety and Pharmacokinetic Study of TAK-285 in Patients With Advanced CancerCompletedNCT00535522Phase 1
• Efficacy of Lapaquistat Acetate on Blood Cholesterol Levels in Treating Subjects With HypercholesterolemiaTerminatedNCT00532558Phase 3
• Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With HypercholesterolemiaTerminatedNCT00532311Phase 3
• Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart FailureTerminatedNCT00521820Phase 3
• Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac DiseaseCompletedNCT00521742Phase 3
• PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE)CompletedNCT00515593
• Safety and Efficacy of ADDERALL XR in the Treatment of Adolescents Aged 13-17 With Attention Deficit Hyperactivity Disorder (ADHD)CompletedNCT00507065Phase 3
• Analog Classroom Study Comparison of ADDERALL XR With STRATTERA in Children Aged 6-12 With ADHDCompletedNCT00506727Phase 4
• Safety and Efficacy of SPD476 (Mesalazine) Given Twice Daily (2.4 g/Day) vs SPD476 Given as a Single Dose (4.8 g/Day) in Subjects With Acute Mild to Moderate Ulcerative ColitisCompletedNCT00503243Phase 3
• Comparison of Nasal Fentanyl and Oral Transmucosal Fentanyl (Actiq) in Cancer Breakthrough Pain (FT-019-IM)CompletedNCT00496392Phase 3
• Safety Study of Pioglitazone Compared To Glyburide on Liver FunctionCompletedNCT00494312Phase 4
• Efficacy of Ramelteon on Insomnia Symptoms Associated With Jet Lag in Healthy Adult VolunteersCompletedNCT00492011Phase 4
• A Trial in Healthy Volunteers, to Evaluate the Tolerability and Cardiac Safety of PrucaloprideCompletedNCT00488215Phase 1
• Efficacy and Safety Study of Prucalopride to Treat Chronic ConstipationCompletedNCT00488137Phase 3
• Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary DyslipidemiaCompletedNCT00487994Phase 3
• Efficacy and Safety Study of Prucalopride for the Treatment of Elderly Patients With Chronic ConstipationCompletedNCT00487422Phase 3
• Efficacy and Safety Study of Prucalopride for the Treatment of Patients With Chronic ConstipationCompletedNCT00485940Phase 3
• Efficacy and Safety Study of Prucalopride for the Treatment of Chronic ConstipationCompletedNCT00483886Phase 3
• Actovegin® Versus Placebo in Patients With Diabetic Polyneuropathy (AV-007-IM)CompletedNCT00483730Phase 3
• Evaluation of Safety of ZyComb® In Patients With Common Cold - ZIP 3000 (XY-005-IM)CompletedNCT00480194
• Efficacy and Safety of Adipose Stem Cells to Treat Complex Perianal Fistulas Not Associated to Crohn´s DiseaseCompletedNCT00475410Phase 3
• Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive EsophagitisCompletedNCT00471094Phase 2
• A Study of SPD465 in Young Adult Drivers With Attention-Deficit Hyperactivity Disorder (ADHD) Using Driving SimulatorsWithdrawnNCT00458445Phase 3
• Conversion From Standard Phosphate Binder Therapy to Fosrenol® (Lanthanum Carbonate) in Chronic Kidney Disease Stage 5TerminatedNCT00452478Phase 4
• The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-induced Changes in GERD-related Symptoms (BY1023/NL511)TerminatedNCT00449813Phase 4
• Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone.CompletedNCT00449553
• Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema SubjectsCompletedNCT00432510Phase 1
• Subjective Efficacy of Ramelteon on Sleep in Adults With Chronic Insomnia.CompletedNCT00414102Phase 4
• Efficacy, Safety and Tolerability Study of TAK-583 in Subjects With Postherpetic NeuralgiaCompletedNCT00377598Phase 2/3
• Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes MellitusTerminatedNCT00376181Phase 3
• TachoSil Paediatric Liver Trial (TC-019-IN)CompletedNCT00365248Phase 3
• Efficacy and Safety of Intranasal Fentanyl in the Treatment of Breakthrough Pain (FT-018-IM)CompletedNCT00362583Phase 3
• Intranasal Fentanyl for the Treatment of Breakthrough Pain in Cancer Patients (FT-017-IM)CompletedNCT00345735Phase 2
• Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior TherapyCompletedNCT00343720Phase 2
• Symptom Assessment in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) or enGERD (Endoscopic-negative GERD) After Treatment With Pantoprazole (BY1023/M3-343)CompletedNCT00336219Phase 3
• Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)CompletedNCT00334880Phase 3
• A Study of Plasma-Derived Human Butyrylcholinesterase Administered IntramuscularlyCompletedNCT00333528Phase 1
• Pharmacokinetic (PK) and Safety Study of Plasma-derived Human Butyrylcholinesterase Administered IntravenouslyCompletedNCT00333515Phase 1
• Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and DyslipidemiaCompletedNCT00331487Phase 3
• Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Non-erosive Reflux or Gastroesophageal Reflux Disease (BY1023/DE-004)CompletedNCT00326027Phase 3
• Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's DiseaseCompletedNCT00325728Phase 2
• Comparison of the Classical Healing Concept With the Complete Remission Concept After Treatment With Pantoprazole in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) (BY1023/M3-342)CompletedNCT00325676Phase 4
• The Use of Lansoprazole to Treat Infants With Symptoms of Gastroesophageal RefluxCompletedNCT00324974Phase 3
• RIAPRE - Non-interventional Registry of Anticoagulation Treatment (BI-006-IT)WithdrawnNCT00317343
• Safety of Ramelteon in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT00316992Phase 4
• Effect of Pantoprazole on the Symptoms of Acid Reflux Disease in Adult Patients (BY1023/M3-341)CompletedNCT00312806Phase 3
• Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.TerminatedNCT00312286Phase 2
• Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008CompletedNCT00308438Phase 2
• Open-Label Study to Assess the Effect of Omeprazole on the Pharmacokinetics of VELCADE in Patients With Either Advanced Solid Tumors or Non-Hodgkin's Lymphoma.CompletedNCT00298779Phase 1
• A Phase 2 Study of Tandutinib in Patients With Newly Diagnosed Acute Myelogenous Leukemia Who Are Considered Ineligible For or Who Decline Treatment With Standard Induction TherapyWithdrawnNCT00297921Phase 1/2
• TachoSil Versus Standard Surgical Treatment for Air Leakage in Pulmonary Lobectomy (TC-021-IM)CompletedNCT00293514Phase 3
• ImproveR International (BI-001-IM)CompletedNCT00290849
• Assess Efficacy and Safety of TachoComb H vs. Standard Surgical Treatment (i.e. Suturing) in Patients Undergoing Prostatectomy (TC-017-AU)CompletedNCT00290836Phase 4
• Efficacy of Lapaquistat Acetate Alone or Combined With Simvastatin in Subjects With HypercholesterolemiaCompletedNCT00286481Phase 3
• Observational Cohort Study of TachoSil (TC-018-IN)CompletedNCT00285623
• A Study of Tarceva for Use in Patients With Relapsed or Refractory Metastatic Non-Small Cell Lung CancerTerminatedNCT00283634Phase 2
• OSHES - Observational Study on Hemostasis in Surgery (TC-022-IT)CompletedNCT00279383
• Efficacy and Safety of FITpatch Compared to Standard Opioid Treatment in Cancer Pain (FT-015-IN)CompletedNCT00279344Phase 3
• MLN518 in Combination With Standard Induction Chemo. for Treatment of Patients With Newly Diagnosed Acute Myelogenous LeukemiaCompletedNCT00274248Phase 1
• Efficacy of Lapaquistat Acetate Alone and With Ezetimibe in Subjects With Primary Dyslipidemia.CompletedNCT00268697Phase 3
• Efficacy of Lapaquistat Acetate Co-Administered With Current Lipid-Lowering Treatment on Blood Cholesterol Levels in Subjects With Homozygous Familial HypercholesterolemiaTerminatedNCT00263081Phase 3
• Determination of a Questionnaire After Treatment With Pantoprazole at Full Dose and Half Dose in Adult Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/UK-506)CompletedNCT00261339Phase 4
• Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708)CompletedNCT00261300Phase 3
• Evaluation of VELCADE Given as Retreatment to Multiple Myeloma Patients for Efficacy, Safety and TolerabilityCompletedNCT00257114Phase 4
• Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia.CompletedNCT00256178Phase 3
• Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.CompletedNCT00251680Phase 3
• PROTECT-TIMI 30 TrialCompletedNCT00250471Phase 3
• Efficacy of Lapaquistat Acetate Alone or Combined With Rosuvastatin in Subjects With HypercholesterolemiaCompletedNCT00249912Phase 3
• Efficacy of Lapaquistat Acetate Alone or Combined With High-Dose Statin Therapy in Subjects With HypercholesterolemiaTerminatedNCT00249899Phase 3
• A Study of MLN8054 in Patients With Advanced Solid TumorsTerminatedNCT00249301Phase 1
• Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant AbuseCompletedNCT00248092Phase 1/2
• Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse HistoriesCompletedNCT00247572Phase 2
• Long-Term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.CompletedNCT00247390Phase 3
• Determination of the Minimal Clinically Important Difference After Treatment With Pantoprazole in Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-340)CompletedNCT00246909Phase 4
• TachoComb S Versus Standard Surgical Treatment in Surgical Resection of Renal Tumour (TC-015-IN)CompletedNCT00241163Phase 3
• Safety and Efficacy of Ramelteon in Adults With Chronic InsomniaCompletedNCT00237497Phase 3
• Efficacy and Safety of Lanthanum Carbonate in Reducing Serum Phosphorus Levels in Subjects With Stage 3 and 4 Chronic Kidney DiseaseCompletedNCT00234702Phase 2
• Efficacy and Safety Study of TAK-128 in Treating Subjects With Diabetic Peripheral NeuropathyCompletedNCT00229437Phase 2
• Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease.CompletedNCT00225264Phase 3
• Maribavir for Prevention of CMV After Stem Cell TransplantsCompletedNCT00223925Phase 2
• A Study to Evaluate the Effect of Lansoprazole on Infants With Gastroesophageal Reflux Disease.CompletedNCT00220818Phase 1
• ADVATE Post Authorization Safety SurveillanceCompletedNCT00214734
• Safety and Efficacy of SPD465 in Adults With ADHDCompletedNCT00202605Phase 2
• Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101CompletedNCT00189982Phase 2/3
• Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive EsophagitisCompletedNCT00175045Phase 2
• A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose AspirinCompletedNCT00175032Phase 3
• Efficacy of Pioglitazone on Macrovascular Outcome in Patients With Type 2 DiabetesCompletedNCT00174993Phase 3
• A Study to Evaluate the Effect of Lansoprazole on Hospitalized Neonates With Gastroesophageal Reflux DiseaseCompletedNCT00174928Phase 1
• Calcium Supplementation in Postmenopausal WomenCompletedNCT00172172Phase 3

← Takeda overview and focus areas